Business ❯ Healthcare ❯ Pharmaceuticals

Drug Pricing

Weight-loss Drugs Medicare Negotiations Pfizer 340B Program E-commerce Generic Drugs Compounded Medications Investment Strategies US Policy Obesity Drugs Rebates Eli Lilly and Novo Nordisk Affordability Solutions Consumer Access Government Regulations Market Regulations R&D Funding Zepbound Sanofi Agreement Wegovy Pharmacy Benefit Managers Novo Nordisk Weight Loss Drugs Ozempic and Wegovy Major Pharmaceutical Companies 340B Drug Pricing Program

Analyses Find Limited Savings as TrumpRx Reaches 54 Drugs

Independent comparisons show several listed medicines cost less abroad.

Novo Nordisk to Cut U.S. List Prices for Wegovy, Ozempic and Rybelsus to $675 in 2027

FTC Proposes Consent Order With Express Scripts to Overhaul Insulin Pricing Incentives

Eli Lilly’s Q4 Beat and Bullish Outlook Give Way to Stock Drop on Low-Cost GLP-1 Pills

Cigna’s Evernorth to End Rebates for Many Plans, Shift to Point-of-Sale Pricing and Cost-Plus Pharmacy Pay

EVERSANA, Waltz Health Announce $6 Billion Merger to Build Tech-Driven Drug Access Platform